Phase II Trial With Metronomic, Capecitabine Plus Oral Vinorelbine for Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Arm B Vinorelbine (Navelbine oral) Capecitabine (Xeloda)|DRUG: Arm A Vinorelbine (Navelbine oral) Capecitabine (Xeloda)
Sponsor: University of Aarhus
Collaborators: Pierre Fabre Laboratories